These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 31248681)
21. Pharmacokinetic/pharmacodynamic-guided gentamicin dosing in critically ill patients: a revisit of the Hartford nomogram. He S; Cheng Z; Xie F Int J Antimicrob Agents; 2022 Jun; 59(6):106600. PubMed ID: 35533792 [TBL] [Abstract][Full Text] [Related]
22. Activity of plazomicin compared with other aminoglycosides against isolates from European and adjacent countries, including Enterobacteriaceae molecularly characterized for aminoglycoside-modifying enzymes and other resistance mechanisms. Castanheira M; Deshpande LM; Woosley LN; Serio AW; Krause KM; Flamm RK J Antimicrob Chemother; 2018 Dec; 73(12):3346-3354. PubMed ID: 30219857 [TBL] [Abstract][Full Text] [Related]
24. A Phase 1 Study of Intravenous Plazomicin in Healthy Adults to Assess Potential Effects on the QT/QTc Interval, Safety, and Pharmacokinetics. Gall J; Choi T; Riddle V; Van Wart S; Gibbons JA; Seroogy J Clin Pharmacol Drug Dev; 2019 Nov; 8(8):1032-1041. PubMed ID: 30650259 [TBL] [Abstract][Full Text] [Related]
25. Antimicrobial activity of plazomicin against Enterobacteriaceae-producing carbapenemases from 50 Brazilian medical centers. Martins AF; Bail L; Ito CAS; da Silva Nogueira K; Dalmolin TV; Martins AS; Rocha JLL; Serio AW; Tuon FF Diagn Microbiol Infect Dis; 2018 Mar; 90(3):228-232. PubMed ID: 29223516 [TBL] [Abstract][Full Text] [Related]
26. Experience with a once-daily dosing program of aminoglycosides in critically ill patients. Buijk SE; Mouton JW; Gyssens IC; Verbrugh HA; Bruining HA Intensive Care Med; 2002 Jul; 28(7):936-42. PubMed ID: 12122533 [TBL] [Abstract][Full Text] [Related]
27. The Impact of Capping Creatinine Clearance on Achieving Therapeutic Vancomycin Concentrations in Neurocritically Ill Patients with Traumatic Brain Injury. Nelson NR; Morbitzer KA; Jordan JD; Rhoney DH Neurocrit Care; 2019 Feb; 30(1):126-131. PubMed ID: 30051194 [TBL] [Abstract][Full Text] [Related]
28. Evaluation of a vancomycin dosing nomogram in achieving high target trough concentrations in Taiwanese patients. Leu WJ; Liu YC; Wang HW; Chien HY; Liu HP; Lin YM Int J Infect Dis; 2012 Nov; 16(11):e804-10. PubMed ID: 22917921 [TBL] [Abstract][Full Text] [Related]
29. Pharmacokinetic/pharmacodynamic evaluation of tobramycin dosing in critically ill patients: the Hartford nomogram does not fit. Xie F; Wang Y; Peng Y; Cheng Z; Li S J Antimicrob Chemother; 2021 Aug; 76(9):2335-2341. PubMed ID: 34096596 [TBL] [Abstract][Full Text] [Related]
30. Pharmacodynamics of plazomicin and a comparator aminoglycoside, amikacin, studied in an in vitro pharmacokinetic model of infection. Noel AR; Attwood M; Bowker KE; Kim A; Krause KM; MacGowan AP Int J Antimicrob Agents; 2019 Nov; 54(5):626-632. PubMed ID: 31299297 [TBL] [Abstract][Full Text] [Related]
31. Comparison of two gentamicin dosing schedules in very low birth weight infants. Rastogi A; Agarwal G; Pyati S; Pildes RS Pediatr Infect Dis J; 2002 Mar; 21(3):234-40. PubMed ID: 12005088 [TBL] [Abstract][Full Text] [Related]
32. Vancomycin dosing nomograms targeting high serum trough levels in different populations: pros and cons. Elyasi S; Khalili H Eur J Clin Pharmacol; 2016 Jul; 72(7):777-88. PubMed ID: 27117446 [TBL] [Abstract][Full Text] [Related]
33. Experience with a once-daily aminoglycoside program administered to 2,184 adult patients. Nicolau DP; Freeman CD; Belliveau PP; Nightingale CH; Ross JW; Quintiliani R Antimicrob Agents Chemother; 1995 Mar; 39(3):650-5. PubMed ID: 7793867 [TBL] [Abstract][Full Text] [Related]
34. Comparison of the next-generation aminoglycoside plazomicin to gentamicin, tobramycin and amikacin. Zhanel GG; Lawson CD; Zelenitsky S; Findlay B; Schweizer F; Adam H; Walkty A; Rubinstein E; Gin AS; Hoban DJ; Lynch JP; Karlowsky JA Expert Rev Anti Infect Ther; 2012 Apr; 10(4):459-73. PubMed ID: 22512755 [TBL] [Abstract][Full Text] [Related]
35. Evaluation of Plazomicin, Tigecycline, and Meropenem Pharmacodynamic Exposure against Carbapenem-Resistant Enterobacteriaceae in Patients with Bloodstream Infection or Hospital-Acquired/Ventilator-Associated Pneumonia from the CARE Study (ACHN-490-007). Kuti JL; Kim A; Cloutier DJ; Nicolau DP Infect Dis Ther; 2019 Sep; 8(3):383-396. PubMed ID: 31254273 [TBL] [Abstract][Full Text] [Related]
36. Development of a dosing nomogram for continuous-infusion meropenem in critically ill patients based on a validated population pharmacokinetic model. Minichmayr IK; Roberts JA; Frey OR; Roehr AC; Kloft C; Brinkmann A J Antimicrob Chemother; 2018 May; 73(5):1330-1339. PubMed ID: 29425283 [TBL] [Abstract][Full Text] [Related]
38. Can Plazomicin Alone or in Combination Be a Therapeutic Option against Carbapenem-Resistant Acinetobacter baumannii? García-Salguero C; Rodríguez-Avial I; Picazo JJ; Culebras E Antimicrob Agents Chemother; 2015 Oct; 59(10):5959-66. PubMed ID: 26169398 [TBL] [Abstract][Full Text] [Related]
39. Optimization of an empiric vancomycin dosing algorithm for improved target concentration attainment in patients with thermal injury. Hill DM; Velamuri SR; Lanfranco J; Romero Legro I; Sinclair SE; Hickerson WL Burns; 2019 Mar; 45(2):423-432. PubMed ID: 30340863 [TBL] [Abstract][Full Text] [Related]
40. A Multicenter, Randomized, Double-Blind, Phase 2 Study of the Efficacy and Safety of Plazomicin Compared with Levofloxacin in the Treatment of Complicated Urinary Tract Infection and Acute Pyelonephritis. Connolly LE; Riddle V; Cebrik D; Armstrong ES; Miller LG Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29378708 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]